{
 "PrintNo":"A5946","Session":2019,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2019-02-20T16:00:05.732379Z",
 "Status":"STRICKEN",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2020-01-08","Committee":"Consumer Affairs And Protection"}],
 "Actions":[
  {"Text":"REFERRED TO CONSUMER AFFAIRS AND PROTECTION","Date":"2019-02-20","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO CONSUMER AFFAIRS AND PROTECTION","Date":"2020-01-08","Chamber":"ASSEMBLY"},
  {"Text":"ENACTING CLAUSE STRICKEN","Date":"2020-07-06","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":537,"Name":"Marcos Crespo","Short":"CRESPO"}],"Title":"Relates to price gouging of medicine",
 "Summary":"Prohibits selling a drug subject to a shortage for an unconscionably excessive price.",
 "LawSection":"General Business Law","LawCode":"Add ยง396-rrr, Gen Bus L",
 "ActClause":"AN ACT to amend the general business law, in relation to the price gouging of medicine",
 "SameAsPrintNo":"S3654-2019"
}